Risk of infection associated with daratumumab treatment for Multiple Myeloma

被引：0
|
作者：
Yousif, Ammar [1 ]
Cui, Haiyan [1 ]
Russell, Samantha [2 ]
Larsen, Ashley [2 ]
Gowin, Krisstina [1 ]
机构：
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
[2] Univ Arizona, Coll Med, Tucson, AZ USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2020年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-39
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [41] Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy
    Dima, Danai
    Dower, Joshua
    Comenzo, Raymond L.
    Varga, Cindy
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7891 - 7903
  • [42] Efficacy and safety of daratumumab for the treatment of multiple myeloma: a series of Cochrane reviews
    Hirsch, C.
    Langer, P.
    Skoetz, N.
    Scheid, C.
    John, L.
    Piechotta, V
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 178 - 178
  • [43] Successful treatment of scleromyxedema with daratumumab, lenalidomide and dexamethasone in a patient with multiple myeloma
    Bettolini, Luca
    Bighetti, Stefano
    Maione, Vincenzo
    Ghini, Iacopo
    Segala, Diego
    Calzavara-Pinton, Piergiacomo
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (04) : e104 - e107
  • [44] Daratumumab for the Treatment of Multiple Myeloma: A Review of Clinical Applicability and Operational Considerations
    Arnall, Justin R.
    Maples, Kathryn T.
    Harvey, R. Donald
    Moore, Donald C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2022, 56 (08) : 927 - 940
  • [45] Meta-analysis of the efficacy and safety of daratumumab in the treatment of multiple myeloma
    Wang, Pei
    Jin, Sheng-Yu
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (29) : 7091 - 7100
  • [46] Daratumumab for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Center Experience
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Neri, Paola
    Luider, Joanne
    Tay, Jason
    Bahlis, Nizar J.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E67 - E68
  • [47] Multiple Myeloma Index for Risk of Infection
    Valkovic, T.
    Gacic, V
    Nacinovic-Duletic, A.
    [J]. JOURNAL OF CANCER, 2018, 9 (12): : 2211 - 2214
  • [48] INFLUENCE OF TREATMENT AND RESPONSE STATUS ON INFECTION RISK IN MULTIPLE-MYELOMA
    PERRI, RT
    HEBBEL, RP
    OKEN, MM
    [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 71 (06): : 935 - 940
  • [49] Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma
    Cliff, Edward R. Scheffer
    Reynolds, Gemma
    Popat, Rakesh
    Teh, Benjamin W.
    Kesselheim, Aaron S.
    Mohyuddin, Ghulam Rehman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (10) : 1949 - +
  • [50] REAL WORLD DATA OF DARATUMUMAB TREATMENT IN PATIENT WITH MULTIPLE MYELOMA: A PORTUGUESE STUDY
    Gomes, A.
    Araujo, A.
    Pio, J.
    Pontes, C.
    Bergantim, R.
    Medeiros, J.
    Martins, O.
    Duarte, A.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S45 - S45
12345